Novavax outlines $400M 2026 revenue framework while targeting cash runway into 2029

Summary

Novavax has outlined a 2026 revenue framework of $400 million while targeting a cash runway into 2029, according to a Seeking Alpha breaking news headline. The report is based on the headline alone, so no further details on the drivers of the framework, its components or the company's reasons are available from the article provided.

Timeline

1. Seeking Alpha

   5 Nov 2026, 18:56 UTCSource ↗

   Seeking Alpha reports that Novavax outlined a $400M 2026 revenue framework while targeting a cash runway into 2029.